Neuroscience
Alzheimer's Disease
100%
Meta-Analysis
47%
Risk Factor
32%
Cognitive Disorders
32%
Systematic Review
30%
Major Depressive Disorder
30%
Blood Plasma
28%
Bipolar Disorder
28%
Quality of Life
28%
Amyloid Protein
28%
Mental Disorder
25%
Cerebrovascular Accident
22%
Placebo
21%
Cognitive Function
20%
Antidepressant
18%
Randomized Controlled Trial
17%
Psychiatry
15%
Parkinson's Disease
15%
Apolipoprotein E
15%
Mood Disorder
14%
Beta Amyloid
14%
Antipsychotic
14%
Cannabis
14%
Haplotype
12%
Mild Cognitive Impairment
12%
Behavior (Neuroscience)
12%
Hallucination
10%
Depressive Disorder
10%
Anxiety Disorder
9%
Diabetes Mellitus
9%
Metabolic Pathway
9%
Single-Nucleotide Polymorphism
9%
Serotonin
9%
Body Mass Index
9%
Electroconvulsive Therapy
8%
Comorbidity
8%
Longitudinal Study
8%
Neurodegenerative Disorder
8%
Sleep Quality
8%
Posttraumatic Stress Disorder
7%
Genome-Wide Association Study
7%
Neurodegeneration
7%
Endophenotype
7%
Naltrexone
7%
Amyloid Precursor Protein
7%
Substance Abuse
7%
ICD-10
6%
Homocysteine
6%
Post-Stroke Depression
6%
Selective Serotonin Reuptake Inhibitor
6%
Working Memory
6%
Executive Function
6%
Tryptophan
6%
Autism
6%
Attention Deficit Hyperactivity Disorder
5%
Auditory Hallucination
5%
Negative Syndrome
5%
Generalized Anxiety Disorder
5%
Ketamine
5%
Drug Therapy
5%
Clozapine
5%
Heroin
5%
Cannabinoid
5%
Diethylstilbestrol
5%
Side Effect
5%
Transcranial Magnetic Stimulation
5%
Gray Matter
5%
Brain Ischemia
5%
Medicine and Dentistry
Alzheimer's Disease
50%
Mental Health
47%
Diseases
36%
Diabetes
33%
Prevalence
26%
Cannabis
23%
Randomized Controlled Trial
23%
Naltrexone
21%
Meta-Analysis
21%
Mental Health Service
18%
Apoplexy
18%
Systematic Review
17%
Major Depressive Episode
16%
Cannabinoid
16%
Quality of Life
14%
Antidepressant
14%
Gene Linkage
13%
Placebo
13%
Bipolar Disorder
12%
Mental Disorder
12%
Cognitive Defect
12%
Biological Marker
11%
COVID-19
11%
Amyloid Beta
11%
Maturity Onset Diabetes of the Young
11%
Emergency Department
11%
Cognitive Decline
11%
Odds Ratio
10%
Amyloid Protein
10%
Clinician
9%
Aboriginal and Torres Strait Islander
9%
Nonalcoholic Fatty Liver
9%
Psychiatrist
9%
Cardiovascular System
9%
Cardiovascular Disease
9%
Psychiatry
9%
Severe Mental Illness
8%
Drug Therapy
8%
Degenerative Disease
8%
Health Care Cost
8%
Cohort Effect
8%
Malignant Neoplasm
8%
Cannabis Use
8%
Antipsychotic
7%
Physical Activity
7%
Chronic Disease
7%
Neurodegeneration
7%
Electroconvulsive Therapy
7%
Mental Health Care
7%
Sirtuin 1
7%
Oral
7%
Health Outcomes
7%
Cohort Analysis
7%
Hallucination
7%
Mild Cognitive Impairment
7%
Implant
7%
Congenital Malformation
7%
Methadone
6%
Hazard Ratio
6%
Parkinson's Disease
6%
Drug Use
6%
Disease
6%
Lifespan
6%
Medicine
6%
Comorbidity
6%
Observational Study
6%
Buprenorphine
6%
Health Service
6%
Diamorphine
6%
Cross Sectional Study
6%
Genotoxicity
5%
Catatonia
5%
Alcohol Consumption
5%
Primary Health Care
5%
Public Health
5%
Opiate
5%
Metabolic Syndrome
5%
Body Mass Index
5%
Posttraumatic Stress Disorder
5%
Autism
5%
Patient Referral
5%
Nursing and Health Professions
Prevalence
42%
Mental Health
42%
Meta Analysis
29%
Quality of Life
26%
Diseases
23%
Confidence Interval
17%
Mental Health Service
17%
Adolescent
14%
Major Depression
14%
Odds Ratio
13%
Psychiatrist
12%
Systematic Review
12%
COVID-19
11%
Cerebrovascular Accident
11%
Primary Medical Care
10%
Bipolar Disorder
9%
Emergency Ward
9%
Alcohol Consumption
9%
Depressive Disorder
9%
Cognitive Defect
9%
Physical Activity
8%
General Practitioner
8%
Health Care
8%
Psychotropic Agent
8%
Antidepressant
8%
Alzheimer's Disease
7%
Practice Guideline
7%
Placebo
7%
Cross-Sectional Study
7%
Comorbidity
6%
Cohort Analysis
6%
Longitudinal Analysis
6%
Electroconvulsive Therapy
5%
Patient Referral
5%
Mental Health Care
5%
Maturity Onset Diabetes of the Young
5%
Logistic Regression Analysis
5%
Health Practitioner
5%
General Practice
5%
Malignant Neoplasm
5%
Mild Cognitive Impairment
5%
Posttraumatic Stress Disorder
5%
Efficacy
5%
Body Mass
5%
Frailty
5%
Patient Health Questionnaire 9
5%